News Research Colorectal Cancer Genetics/Genomics Decision-Making Support

ML Model Uses Methylation Patterns to Identify Tissue of Origin 

April 22, 2026 By Lisa Astor 6 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter
Objective:

To develop a machine learning model that predicts tissue of origin in cancers of unknown primary using a focused set of DNA methylation patterns.

Key Findings:
  • The model achieved an area under the curve of 0.998 and classification accuracy of 0.954 in internal validation.
  • In the TCGA held-out test cohort, the model maintained a high area under the curve of 0.998 and accuracy of 0.947.
  • Errors in classification reflected biological similarities rather than model failures.
Interpretation:

The model effectively captures tumor biology through DNA methylation patterns, offering a promising tool for identifying tissue of origin in cancers of unknown primary.

Limitations:
  • The study primarily focused on a limited set of cancer types.
  • Further validation is needed in cohorts of patients with true cancers of unknown primary.
Conclusion:

The developed classifier has the potential to improve site-directed therapy decision-making for patients with cancers of unknown primary, complementing existing genomic profiling methods.

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content